ArticleCancer management and research2020

MiR-218-5p Suppresses the Progression of Retinoblastoma Through Targeting NACC1 and Inhibiting the AKT/mTOR Signaling Pathway.

Li Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.